相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
Ke Hu et al.
PHYTOMEDICINE (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
Maximilian F. Konig et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
Yu Bo et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Prevalence and Prognostic Association of a Clinical Diagnosis of Depression in Adult Congenital Heart Disease: Results of the Boston Adult Congenital Heart Disease Biobank
Matthew R. Carazo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
Li Ni et al.
FRONTIERS OF MEDICINE (2020)
China is promoting coronavirus treatments based on unproven traditional medicines
David Cyranoski
NATURE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Hai-xia Su et al.
ACTA PHARMACOLOGICA SINICA (2020)
Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
Qinhai Ma et al.
VIRUSES-BASEL (2017)
Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers
Hongxian Pang et al.
CLINICAL DRUG INVESTIGATION (2016)
Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice
Hengfei Shi et al.
SCIENTIFIC REPORTS (2016)
Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects
Min Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide-stimulated murine alveolar macrophages
Yuan Gao et al.
PHYTOMEDICINE (2014)
The dose-response relationship in Phase I clinical trials and beyond: use, meaning, and assessment
G Emilien et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
